Inventurus Knowledge Solutions IPO is set to open for subscription on December 12, 2024, and will close on December 16, 2024. This IPO is a book-built issue with a total size of ₹2,497.92 crores, entirely comprising an offer for sale of 1.88 crore equity shares. The price band for the IPO is set at ₹1265 to ₹1329 per share, and the minimum lot size is 11 shares, requiring a minimum investment of ₹14,619 for retail investors.
The IPO allotment date is December 17, 2024, and the shares are expected to be listed on the BSE and NSE on December 19, 2024. The retail quota is 10%, while QIB and HNI quotas are 75% and 15%, respectively.
Financially, Inventurus Knowledge Solutions reported revenue of ₹1,817.93 crores in 2024, a significant increase from ₹1,031.30 crores in 2023. Its profit also grew from ₹305.23 crores in 2023 to ₹370.49 crores in 2024. Based on these robust financials, the IPO is deemed suitable for long-term investment.
Overview of Contents
About Inventurus Knowledge Solutions IPO
Inventurus Knowledge Solutions Limited (IKS Health) is a leading healthcare technology platform established in 2006, dedicated to transforming patient care through advanced, innovative solutions. Catering primarily to markets in the United States, Canada, and Australia, the company enables healthcare providers to transition from traditional “fee-for-service” models to a more efficient “fee-for-value” payment structure.
IKS Health supports over 778 healthcare organizations, including multi-specialty medical groups, single-specialty medical groups, and ancillary healthcare systems. Key clients include prominent names such as Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management. With a workforce of 13,528 employees, including 2,612 clinically-trained professionals, IKS Health ensures quality delivery across its services.
The platform specializes in reducing the administrative burden on healthcare providers by managing tasks such as medical documentation, clinical support, virtual medical scribing, and administrative workflows. These services help doctors and healthcare providers focus more on patient care. It also offers comprehensive solutions for outpatient care (medical services not requiring hospital admission) and inpatient care (medical treatment involving hospital stays).
Inventurus Knowledge Solutions IPO Details
| Particulars | Details |
|---|---|
| IPO Date | December 12, 2024, to December 16, 2024 |
| Listing Date | December 19, 2024 (Tentative) |
| Face Value | ₹1 per share |
| Price Band | ₹1265 to ₹1329 per share |
| Lot Size | 11 Shares |
| Total Issue Size | 18,795,510 shares (aggregating up to ₹2,497.92 Cr) |
| Offer for Sale | 18,795,510 shares of ₹1 (aggregating up to ₹2,497.92 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Pre-Issue Shareholding | 171,573,159 shares |
| Post-Issue Shareholding | 171,573,159 shares |
| Retail Investor Quota | 10% |
| Qualified Institutional Buyers (QIB) | 75% |
| Non-Institutional Investors (HNI) | 15% |
| Minimum Investment | ₹14,619 (11 shares at upper price band of ₹1329) |
| Key Clients | Mass General Brigham Inc., Texas Health Care PLLC, The GI Alliance Management |
| Revenue (FY 2024) | ₹1,817.93 crores |
| Net Income (FY 2024) | ₹370.49 crores |
| Employee Strength | 13,528 employees, including 2,612 clinically-trained professionals |
| Awards and Recognition | Healthcare Leadership Award (2019), Best Blended Learning Award (2020), TISS LeapVault CLO Award (2021), Top 3 in Innovation in Analytics (2022) |
Inventurus Knowledge Solutions IPO Dates
| Event | Date |
|---|---|
| IPO Open Date | Thursday, December 12, 2024 |
| IPO Close Date | Monday, December 16, 2024 |
| Cut-off Time for UPI Mandate Confirmation | 5 PM on December 16, 2024 |
| Basis of Allotment Finalization | Tuesday, December 17, 2024 |
| Initiation of Refunds | Wednesday, December 18, 2024 |
| Credit of Shares to Demat Accounts | Wednesday, December 18, 2024 |
| Listing Date | Thursday, December 19, 2024 |
Inventurus Knowledge Solutions IPO Lot Size and Investment Details
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Minimum) | 1 | 11 | ₹14,619 |
| Retail (Maximum) | 13 | 143 | ₹190,047 |
| S-HNI (Minimum) | 14 | 154 | ₹204,666 |
| S-HNI (Maximum) | 68 | 748 | ₹994,092 |
| B-HNI (Minimum) | 69 | 759 | ₹1,008,711 |
Inventurus Knowledge Solutions IPO Reservation Details
| Investor Category | Shares Offered |
|---|---|
| Qualified Institutional Buyers (QIB) | Not less than 75% of the Offer |
| Retail Individual Investors (RII) | Not more than 10% of the Offer |
| Non-Institutional Investors (NII/HNI) | Not more than 15% of the Offer |
Inventurus Knowledge Solutions IPO Promoter Holding
nventurus Knowledge Solutions is backed by a strong promoter group, including Sachin Gupta and the Jhunjhunwala family trusts—Rekha Jhunjhunwala, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust, and Nishtha Jhunjhunwala Discretionary Trust. This promoter group is known for its strategic leadership and financial expertise, which adds credibility to the company and its growth prospects.
Promoter Shareholding Details
| Stage | Percentage Holding |
|---|---|
| Pre-Issue Holding | 69.73% |
| Post-Issue Holding | 60.61% |
Inventurus Knowledge Solutions IPO – Company Financial Report
The financial performance of Inventurus Knowledge Solutions highlights the company’s impressive growth trajectory, especially in the last two years. With significant increases in both revenue and profit, the company has demonstrated its ability to scale operations effectively while maintaining profitability. This growth is supported by its diverse range of healthcare technology services and a strong client base across the US, Canada, and Australia.
| Period Ended | Revenue (₹ in Crores) | Expense (₹ in Crores) | Profit After Tax (₹ in Crores) | Assets (₹ in Crores) |
|---|---|---|---|---|
| FY 2022 | ₹763.63 | ₹496.21 | ₹232.97 | ₹787.52 |
| FY 2023 | ₹1,031.30 | ₹669.91 | ₹305.23 | ₹988.31 |
| FY 2024 | ₹1,817.93 | ₹1,416.27 | ₹370.49 | ₹3,027.52 |
| September 2024 | ₹1,294.61 | ₹1,028.57 | ₹208.58 | ₹2,790.52 |
Inventurus Knowledge Solutions IPO Valuation – FY2024
The valuation metrics of Inventurus Knowledge Solutions offer insights into the company’s financial performance, profitability, and efficiency. The company has demonstrated strong returns and profitability, making it a promising investment option for long-term investors. Below are the key performance indicators (KPIs) for the FY2024 valuation:
| KPI | Values |
|---|---|
| Return on Equity (ROE) | 32.00% |
| Return on Capital Employed (ROCE) | 31.56% |
| EBITDA Margin | 28.62% |
| Profit After Tax (PAT) Margin | 20.38% |
| Debt to Equity Ratio | 0.06 |
| Earnings Per Share (EPS) | ₹22.37 (Basic) |
| Price/Earnings (P/E) Ratio | N/A |
| Return on Net Worth (RoNW) | 32.00% |
| Net Asset Value (NAV) | ₹69.70 |
Objects of the Issue
Inventurus Knowledge Solutions IPO is a “Offer for Sale” (OFS), meaning the company itself will not receive any funds from the proceeds of the offer. Instead, the entire amount raised will go directly to the Selling Shareholders, after deducting any related expenses. This means the funds will be utilized by the existing shareholders who are selling their shares, rather than the company itself. This type of offering allows the selling shareholders to monetize their holdings without involving the company in raising capital.
Inventurus Knowledge Solutions IPO Registrar
Link Intime India Private Limited
C-101, 1st Floor, 247 Park, L.B.S. Marg
Vikhroli (West), Mumbai 400 083
Maharashtra, India
Phone: +91 810 811 4949
E-mail:Â ikshealth.ipo@linkintime.co.in
Website: www.linkintime.co.in/Initial_Offer/public-issues.html
Company Address
Inventurus Knowledge Solutions Limited
Building No. 5 & 6, Unit No. 801,
8th Floor, Mindspace SEZ,
Thane Belapur Road, Airoli,
Navi Mumbai, Thane,
Maharashtra – 400 708, India
Telephone no.: +91 22 3964 3205
Email:Â company.secretary@ikshealth.com
Website: www.ikshealth.com
Conclusion
Inventurus Knowledge Solutions IPO presents a promising investment opportunity for those looking to participate in the growing healthcare technology sector. With a solid track record of financial growth, the company has demonstrated strong revenue and profit performance, particularly in the fiscal year 2024. The IPO offers investors the chance to invest in a well-established platform serving healthcare organizations globally, with a solid client base in the US, Canada, and Australia.
While the company itself will not benefit directly from the funds raised due to the Offer for Sale structure, investors may find the IPO attractive due to the company’s competitive strengths, including its diversified service offerings and strong brand recognition in the healthcare industry. The IPO’s price band of ₹1265 to ₹1329 per share, coupled with the company’s consistent growth and future prospects, makes it an appealing choice for long-term investors.
Inventurus Knowledge Solutions IPO – FAQs
What is the IPO opening and closing date?
The IPO opens on December 12, 2024, and closes on December 16, 2024.
What is the price band for the IPO?
The price band is ₹1265 to ₹1329 per share.
What is the lot size for the IPO?
The minimum lot size is 11 shares.
What is the total issue size of the IPO?
The total issue size is 18,795,510 shares, aggregating up to ₹2,497.92 crores.
What is the basis of allotment date?
The basis of allotment will be finalized on December 17, 2024.
When will the shares be listed?
The shares are expected to list on BSE and NSE on December 19, 2024.
What is the IPO structure?
The IPO is an Offer for Sale (OFS), with no fresh issue of shares by the company.
What percentage of shares are reserved for retail investors?
10% of the shares are reserved for retail investors.
What are the key financials of the company?
The company reported a revenue of ₹1,817.93 crores and a profit of ₹370.49 crores for FY 2024.